Bellevue Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bellevue Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Hold	10,335	–	–	0.1%	79
2026 Q1	$143K	Hold	10,335	–	–	0.07%	91
2025 Q4	$168K	Hold	10,335	–	–	0.05%	87
2025 Q3	$155K	Hold	10,335	–	–	0.07%	88
2025 Q2	$120K	Hold	10,335	–	–	0.06%	95
2025 Q1	$76.8K	Hold	10,335	–	–	0.04%	119
2024 Q4	$62K	Hold	10,335	–	–	0.03%	135
2024 Q3	$52.9K	Hold	10,335	–	–	0.03%	158
2024 Q2	$37.4K	Hold	10,335	–	–	0.02%	175
2024 Q1	$33.2K	Sell	10,335 -250	-2%	-$967	0.02%	186
2023 Q4	$51.9K	Hold	10,585	–	–	0.05%	146
2023 Q3	$57.7K	Hold	10,585	–	–	0.04%	121
2023 Q2	$70.9K	Hold	10,585	–	–	0.04%	117
2023 Q1	$93.5K	Hold	10,585	–	–	0.06%	93
2022 Q4	$78.8K	Sell	10,585 -162	-2%	-$1.26K	0.06%	110
2022 Q3	$77K	Hold	10,747	–	–	0.06%	114
2022 Q2	$85K	Hold	10,747	–	–	0.06%	108
2022 Q1	$152K	Hold	10,747	–	–	0.09%	85
2021 Q4	$302K	Sell	10,747 -150	-1%	-$4.6K	0.18%	57
2021 Q3	$371K	Buy	10,897 +310	+3%	+$11.2K	0.23%	49
2021 Q2	$433K	Hold	10,587	–	–	0.26%	44
2021 Q1	$430K	Buy	10,587 +162	+2%	+$8.77K	0.27%	48
2020 Q4	$671K	Hold	10,425	–	–	0.41%	38
2020 Q3	$507K	Hold	10,425	–	–	0.35%	42
2020 Q2	$504K	Hold	10,425	–	–	0.52%	39
2020 Q1	$335K	Buy	10,425 +10,150	+3,691%	+$283K	0.35%	54
2019 Q4	$8K	Buy	+275	New	+$7.9K	0.01%	324

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bellevue Asset Management's ADPT Position: Q2 2026 in Review

Bellevue Asset Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 10,335 shares worth $222K. The position accounts for 0.1% of the portfolio, ranked #79.

Bellevue Asset Management first reported a position in ADPT in Q4 2019 and has held it in 27 quarters since. The position peaked at $671K in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Bellevue Asset Management held 10,335 shares of Adaptive Biotechnologies worth $222K as of Q2 2026.
Bellevue Asset Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up 0.1% of Bellevue Asset Management's portfolio in Q2 2026, its #79 holding.
Bellevue Asset Management first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 27 quarters since.
Bellevue Asset Management's Adaptive Biotechnologies position peaked at $671K in Q4 2020.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.